zoledronic acid has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fulchino, LA; Kim, CA; Kim, DH; Kim, SC; Rogers, JR; Solomon, DH | 1 |
| Hale, SL; Hwang, H; Kloner, RA; Leeka, J | 1 |
| Avcu, F; Baran, Y; Ural, AU | 1 |
1 review(s) available for zoledronic acid and Myocardial Infarction
| Article | Year |
|---|---|
Bisphosphonates and risk of cardiovascular events: a meta-analysis.
Topics: Atrial Fibrillation; Bone Density Conservation Agents; Cardiovascular Diseases; Databases, Factual; Diphosphonates; Follow-Up Studies; Humans; Imidazoles; Myocardial Infarction; Odds Ratio; Osteoporosis; Risk; Stroke; Zoledronic Acid | 2015 |
2 other study(ies) available for zoledronic acid and Myocardial Infarction
| Article | Year |
|---|---|
Effects of zoledronate in the repair of chronically infarcted rat myocardium.
Topics: Animals; Chronic Disease; Diphosphonates; Female; Heart; Imidazoles; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Zoledronic Acid | 2010 |
Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer.
Topics: Animals; Bone Density Conservation Agents; Breast Neoplasms; Coronary Artery Disease; Diphosphonates; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Myocardial Infarction; Risk Factors; Zoledronic Acid | 2007 |